Less Chronic Pain After Lichtenstein Hernioplasty Using the Self-gripping Parietex Progrip Mesh
HIPPO
Multicentre Randomised Controled Trial Comparing the Effect of a New Self-gripping Lightweight Polyester Mesh and a Normal Sutured Lightweight Polyester Mesh on the Incidence of Chronic Inguinodynia in Lichtenstein Hernioplasty.
1 other identifier
interventional
400
1 country
2
Brief Summary
Chronic pain after Lichtenstein hernioplasty is a common problem with an incidence of 11%. Many factors influence the onset and persistence of pain. Mesh characteristics and fixation have been pointed as important etiologic factors. This study compares two types of fixation for the same mesh. The mesh used is a lightweight parietex mesh. In the control group this mesh will be fixed with non absorbable sutures. In the study group sutures will not be needed because of self gripping microhooks on the surface of the mesh. Methods: The HIPPO trial is a multicenter double blind randomized clinical trial. Patients will be randomly allocated to the sutured mesh or the self-gripping mesh. Hernia repair will be done according to Lichtenstein as described by Amid et all. Included will be all unilateral primary inguinal hernia in man patients aged 18 years or older not meeting the exclusion criteria. Patients will be followed for two years. The main endpoint is the amount of post-operative chronic pain evaluated by VAS scores. The existence of neuropathic pain will be evaluated by the Paindetect questionnaire (and a bedside variant of the QST). Secondary endpoints are recurrence rate, post-operative complications, costs, hospital stay, QOL, return to work and daily activities, genital and sexual problems. To demonstrate a difference in VAS score of 10 with α=0.05 and power 80% a sample size of 400 patients is calculated. Discussion: Hypothesized is that the self gripping non-sutured mesh (Parietex Progrip) will cause less post-operative and chronic pain without enhancing the recurrence rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Sep 2010
Longer than P75 for phase_4
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 6, 2013
CompletedFirst Posted
Study publicly available on registry
April 12, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedApril 12, 2013
April 1, 2013
4.5 years
February 6, 2013
April 9, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of chronic post-operative inguinal pain
The definition of chronic pain given by the IASP will be used.
12 months
Secondary Outcomes (1)
Recurrence rate
12 months
Other Outcomes (4)
per- and post operative complications
3 months
Operating time
Day of surgery
Quality of life
12 months
- +1 more other outcomes
Study Arms (2)
Parietex Progrip mesh
EXPERIMENTALVentral hernioplasty using a (self gripping / self adhering / self fixating) Progrip mesh not needing fixation devices
Parietex Mesh
ACTIVE COMPARATORVentral hernioplasty using a polyester mesh fixed with non absorbable sutures as described by Lichtenstein/Amid
Interventions
Lichtenstein hernioplasty using a self fixating Parietex Progrip mesh not needing any fixating devices
Eligibility Criteria
You may qualify if:
- Primary unilateral inguinal hernia
- Capacitated male person
- Age ≥ 18 years
You may not qualify if:
- Concurrent femoral hernia
- Incarcerated or strangulated inguinal hernia
- ASA 4 or ASA 5
- Impaired adequate follow up
- Participation in another trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Groene Hart Ziekenhuislead
- Erasmus Medical Centercollaborator
Study Sites (2)
Groene Hart Ziekenhuis
Gouda, 2800BB, Netherlands
Sint Franciscus Gasthuis
Rotterdam, 3045 PM, Netherlands
Related Publications (1)
Molegraaf MJ, Grotenhuis B, Torensma B, de Ridder V, Lange JF, Swank DJ. The HIPPO Trial, a Randomized Double-blind Trial Comparing Self-gripping Parietex Progrip Mesh and Sutured Parietex Mesh in Lichtenstein Hernioplasty: A Long-term Follow-up Study. Ann Surg. 2017 Dec;266(6):939-945. doi: 10.1097/SLA.0000000000002169.
PMID: 28257318DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Johan F Lange, Prof
Erasmus Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 6, 2013
First Posted
April 12, 2013
Study Start
September 1, 2010
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
April 12, 2013
Record last verified: 2013-04